Loading publications…
The last 5 uploaded publications
Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis
Anna Galligan, Amir Iravani, Arian Lasocki, Roslyn Wallace, Alison M. Weppler, Nirupa Sachithanandan, Cherie Chiang, Peter G. Colman, John M. Wentworth, Lavinia Spain, George Au‐Yeung, Belinda Lee, Thomas W. H. Kay, Rodney J. Hicks, Shahneen Sandhu, Balasubramanian Krishnamurthy (2023). Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis. , 14, DOI: https://doi.org/10.3389/fendo.2023.1295865.
Article62 days agoIncreased Thyroidal Activity on Routine FDG-PET/CT after Combination Immune Checkpoint Inhibition: Temporal Associations with Clinical and Biochemical Thyroiditis
Anna Galligan, Roslyn Wallace, Balasubramanian Krishnamurthy, Thomas W. H. Kay, Nirupa Sachithanandan, Cherie Chiang, Shahneen Sandhu, Rodney J. Hicks, Amir Iravani (2023). Increased Thyroidal Activity on Routine FDG-PET/CT after Combination Immune Checkpoint Inhibition: Temporal Associations with Clinical and Biochemical Thyroiditis. , 15(24), DOI: https://doi.org/10.3390/cancers15245803.
Article62 days agoIncreased Thyroidal Activity on Routine FDG-PET/CT after Combination Immune Checkpoint Inhibition: Temporal Associations with Clinical and Biochemical Thyroiditis
Anna Galligan, Roslyn Wallace, Balasubramanian Krishnamurthy, Thomas W. H. Kay, Nirupa Sachithanandan, Cherie Chiang, Shahneen Sandhu, Rodney J. Hicks, Amir Iravani (2023). Increased Thyroidal Activity on Routine FDG-PET/CT after Combination Immune Checkpoint Inhibition: Temporal Associations with Clinical and Biochemical Thyroiditis. , 15(24), DOI: https://doi.org/10.3390/cancers15245803.
Article62 days agoFDG PET/CT Prognostic Markers in Patients with Advanced Melanoma Treated with Ipilimumab and Nivolumab
Amir Iravani, Roslyn Wallace, Serigne Lo, Anna Galligan, Alison M. Weppler, Rodney J. Hicks, Shahneen Sandhu (2023). FDG PET/CT Prognostic Markers in Patients with Advanced Melanoma Treated with Ipilimumab and Nivolumab. , 307(3), DOI: https://doi.org/10.1148/radiol.221180.
Article62 days agoFDG-PET metabolic tumor volume in advanced melanoma treated with ipilimumab and nivolumab (ipi/nivo).
Amir Iravani, Roslyn Wallace, Serigne Lo, Anna Galligan, Alison M. Weppler, George Au‐Yeung, Damien Kee, Peter K. H. Lau, Benjamin Brady, Belinda Lee, Grant A. McArthur, Shahneen Sandhu, Rodney J. Hicks (2020). FDG-PET metabolic tumor volume in advanced melanoma treated with ipilimumab and nivolumab (ipi/nivo).. , 38(15_suppl), DOI: https://doi.org/10.1200/jco.2020.38.15_suppl.10041.
Article62 days ago